Genetic variants and prostate cancer risk: Candidate replication and exploration of viral restriction genes

Cancer Epidemiology Biomarkers and Prevention

Volumn 18, Issue 7, 2009, Pages 2137-2144

  Breyer, Joan P ^a   McReynolds, Kate M ^a   Yaspan, Brian L ^a   Bradley, Kevin M ^a   Dupont, William D ^a   Smith, Jeffrey R ^a,b  

^a VANDERBILT INGRAM CANCER CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CANCER RISK; CAUCASIAN; COMORBIDITY; CONTROLLED STUDY; EZH2 GENE; FAMILIAL CANCER; FAMILY HISTORY; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; NKX3 1 GENE; NUCLEOTIDE SEQUENCE; POPULATION; PRIORITY JOURNAL; PROSTATE CANCER; RBM9 GENE; RISK ASSESSMENT; RNASEL GENE; STATISTICAL SIGNIFICANCE; VIRUS RESTRICTION GENE; XPR1 GENE;

AGE OF ONSET; AGED; CASE-CONTROL STUDIES; CHROMOSOMES, HUMAN, X; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSTATIC NEOPLASMS; RETROVIRIDAE INFECTIONS; RISK FACTORS;

EID: 67650456214     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-08-1223     Document Type: Article

References (52)

1. Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000;343: 78 - 85.
2. Page WF, Braun MM, Partin AW, Caporaso N, WalshP. Heredity and prostate cancer: a study of World War II veteran twins. Prostate 1997;33:240 - 5.
3. Langeberg WJ, Isaacs WB, Stanford JL. Genetic etiology of hereditary prostate cancer. Front Biosci 2007;12:4101 - 10.
4. Naylor SL. SNPs associated withprostate cancer risk and prognosis. Front Biosci 2007;12:4111 - 31.
5. Amundadottir LT, Sulem P, Gudmundsson J, et al. A common variant associated withprost ate cancer in European and African populations. Nat Genet 2006;38:652 - 8.
6. Eeles RA, Kote-Jarai Z, Giles GG, et al. Multiple newly identified loci associated withprostate cancer susceptibility. Nat Genet 2008;40: 316 - 21.
7. Thomas G, Jacobs KB, Yeager M, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet 2008; 40:310 - 5.
8. Dong B, Kim S, Hong S, et al. An infectious retrovirus susceptible to an IFN antiviral pathway from human prostate tumors. Proc Natl Acad Sci U S A 2007;104:1655 - 60.
9. Urisman A, Molinaro RJ, Fischer N, et al. Identification of a novel γ-retrovirus in prostate tumors of patients homozygous for R462Q RNASEL variant. PLoS Pathog 2006;2:e25.
10. Goddard KA, Witte JS, Suarez BK, Catalona WJ, Olson JM. Modelfree linkage analysis withcovariates confirms linkage of prostate cancer to chromosomes 1 and 4. Am J Hum Genet 2001;68:1197 - 206.
11. Camp NJ, Cannon-Albright LA, Farnham JM, et al. Compelling evidence for a prostate cancer gene at 22q12.3 by the International Consortium for Prostate Cancer Genetics. Hum Mol Genet 2007;16: 1271 - 8.
12. Lemay J, Maidou-Peindara P, Bader T, et al. HuR interacts with human immunodeficiency virus type 1 reverse transcriptase, and modulates reverse transcription in infected cells. Retrovirology 2008;5:47.
13. Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA. Posttranscriptional regulation of RNase-L expression is mediated by the 3′-untranslated region of its mRNA. J Biol Chem 2007;282:7950 - 60.
14. Johanneson B, McDonnell SK, Karyadi DM, et al. Fine mapping of familial prostate cancer families narrows the interval for a susceptibility locus on chromosome 22q12.3 to 1.36 Mb. Hum Genet 2008; 123:65 - 75.
15. Levy JA. Xenotropism: the elusive viral receptor finally uncovered. Proc Natl Acad Sci U S A 1999;96:802 - 4.
16. Santiago ML, Montano M, Benitez R, et al. Apobec3 encodes Rfv3, a gene influencing neutralizing antibody control of retrovirus infection. Science 2008;321:1343 - 6.
17. Santa-Marta M, Aires da Silva F, Fonseca AM, Rato S, Goncalves J. HIV-1 Vif protein blocks the cytidine deaminase activity of B-cell specific AID in E. coli by a similar mechanism of action. Mol Immunol 2007;44:583 - 90.
18. SmithJR, Freije D, Carpten JD, et al. Major susceptibility locus for prostate cancer on chromosome 1 suggested by a genome-wide search. Science 1996;274:1371 - 4.
19. Rosenberg BR, Papavasiliou FN. Beyond SHM and CSR: AID and related cytidine deaminases in the host response to viral infection. Adv Immunol 2007;94:215 - 44.
20. Dumur CI, Dechsukhum C, Ware JL, et al. Genome-wide detection of LOH in prostate cancer using human SNP microarray technology. Genomics 2003;81:260 - 9.
21. Stanford JL, McDonnell SK, Friedrichsen DM, et al. Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness. Prostate 2006;66:317 - 25.
22. SaitohT, Tun-Kyi A, Ryo A, et al. Negative regulation of interferonregulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pin1. Nat Immunol 2006;7:598 - 605.
23. Watashi K, Khan M, Yedavalli VR, Yeung ML, Strebel K, Jeang KT. Human immunodeficiency virus-1 replication and regulation of APOBEC3G by peptidyl prolyl isomerase Pin1. J Virol 2008.
24. Neville PJ, Conti DV, Krumroy LM, et al. Prostate cancer aggressiveness locus on chromosome segment 19q12-13.1 identified by linkage and allelic imbalance studies. Genes Chromosomes Cancer 2003;36:332 - 9.
25. Ryo A, Uemura H, Ishiguro H, et al. Stable suppression of tumorigenicity by Pin1-targeted RNA interference in prostate cancer. Clin Cancer Res 2005;11:7523 - 31.
26. Wiklund F, Gillanders EM, Albertus JA, et al. Genome-wide scan of Swedishfamilies with hereditary prostate cancer: suggestive evidence of linkage at 5q11.2 and 19p13.3. Prostate 2003;57:290 - 7.
27. Witte JS, Suarez BK, Thiel B, et al. Genome-wide scan of brothers: replication and fine mapping of prostate cancer susceptibility and aggressiveness loci. Prostate 2003;57:298 - 308.
28. Braaten D, Luban J. Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells. EMBO J 2001;20: 1300 - 9.
29. Christensen GB, Camp NJ, Farnham JM, Cannon-Albright LA. Genome-wide linkage analysis for aggressive prostate cancer in Utah high-risk pedigrees. Prostate 2007;67:605 - 13.
30. Suarez BK, Lin J, Burmester JK, et al. A genome screen of multiplex sibships with prostate cancer. Am J Hum Genet 2000;66:933 - 44.
31. Xu J, Gillanders EM, Isaacs SD, et al. Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families. Prostate 2003;57:320 - 5.
32. Gudmundsson J, Sulem P, Rafnar T, et al. Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer. Nat Genet 2008;40:281 - 3.
33. Haiman CA, Patterson N, Freedman ML, et al. Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 2007;39:638 - 44.
34. Yeager M, Orr N, Hayes RB, et al. Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 2007; 39:645 - 9.
35. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004;74:106 - 20.
36. Stephens M, Smith NJ, Donnelly P. A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 2001;68:978 - 89.
37. Fallin D, Cohen A, Essioux L, et al. Genetic analysis of case/ control data using estimated haplotype frequencies: application to APOE locus variation and Alzheimer's disease. Genome Res 2001; 11:143 - 51.
38. Yaspan BL, McReynolds KM, Elmore JB, Breyer JP, Bradley KM, Smith JR. A haplotype at chromosome Xq27.2 confers susceptibility to prostate cancer. Hum Genet 2008;123:379 - 86.
39. Li H, Tai BC. RNASEL gene polymorphisms and the risk of prostate cancer: a meta-analysis. Clin Cancer Res 2006;12:5713 - 9.
40. Rennert H, Zeigler-Johnson CM, Addya K, et al. Association of susceptibility alleles in ELAC2/HPC2, RNASEL/HPC1, and MSR1 withprostate cancer severity in European American and African American men. Cancer Epidemiol Biomarkers Prev 2005;14:949 - 57.
41. Bachmann N, Hoegel J, Haeusler J, et al. Mutation screen and association study of EZH2 as a susceptibility gene for aggressive prostate cancer. Prostate 2005;65:252 - 9.
42. Gelmann EP, Steadman DJ, Ma J, et al. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Cancer Res 2002;62:2654 - 9.
43. Cheng I, Plummer SJ, Jorgenson E, et al. 8q24 and prostate cancer: association withadvanced disease and meta-analysis. Eur J Hum Genet 2008;16:496 - 505.
44. Helfand BT, Loeb S, Cashy J, et al. Tumor characteristics of carriers and noncarriers of the deCODE 8q24 prostate cancer susceptibility alleles. J Urol 2008;179:2197 - 201; discussion 2202.
45. Wang L, McDonnell SK, Slusser JP, et al. Two common chromosome 8q24 variants are associated withincrea sed risk for prostate cancer. Cancer Res 2007;67:2944 - 50.
46. Schumacher FR, Feigelson HS, Cox DG, et al. A common 8q24 variant in prostate and breast cancer from a large nested case-control study. Cancer Res 2007;67:2951 - 6.
47. Severi G, Hayes VM, Padilla EJ, et al. The common variant rs1447295 on chromosome 8q24 and prostate cancer risk: results from an Australian population-based case-control study. Cancer Epidemiol Biomarkers Prev 2007;16:610 - 2.
48. Suuriniemi M, Agalliu I, Schaid DJ, et al. Confirmation of a positive association between prostate cancer risk and a locus at chromosome 8q24. Cancer Epidemiol Biomarkers Prev 2007;16:809 - 14.
49. Suo G, Han J, Wang X, Zhang J, Zhao Y, Dai J. Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 2005;337: 1047 - 51.
50. Cantz T, Key G, Bleidissel M, et al. Absence of OCT4 expression in somatic tumor cell lines. Stem Cells 2008;26:692 - 7.
51. Zheng SL, Ju JH, Chang BL, et al. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Cancer Res 2006;66:69 - 77.
52. Camp NJ, Farnham JM, Cannon-Albright LA. Localization of a prostate cancer predisposition gene to an 880-kb region on chromosome 22q12.3 in Utah high-risk pedigrees. Cancer Res 2006; 66:10205 - 12.